Report #2866111

Received Oct 15, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: 54 yrs
State: KS
Recovered: Unknown
Vaccinated: Sep 22, 2025
Onset: Sep 22, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	UNK	55KB9	—

Symptoms (1)

Product preparation issue

Symptom narrative

administered only adjuvant portion of Shingrix; administered only adjuvant portion of Shingrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of inappropriate dose of vaccine administered in a 54-year-old male patient who received Herpes zoster (Shingrix) (batch number 55KB9, expiry date 26-APR-2027) for prophylaxis. On 22-SEP-2025, the patient received Shingrix. On 22-SEP-2025, an unknown time after receiving Shingrix, the patient experienced inappropriate dose of vaccine administered (Verbatim: administered only adjuvant portion of Shingrix) and inappropriate preparation of medication (Verbatim: administered only adjuvant portion of Shingrix). The outcome of the inappropriate dose of vaccine administered and inappropriate preparation of medication were not applicable. Additional Information: GSK Receipt Date: 30-SEP-2025 The nurse explained they administered only adjuvant portion of Shingrix to a patient on 22nd September 2025.